Introduction
============

*Staphylococcus aureus* is an important zoonotic pathogen that is responsible for a variety of infectious diseases characterized by septicemia and sepsis ([@B12]; [@B39]). China is one of the world's largest pork producers with more than 470 million pigs, accounting for ∼50% of the total numbers in the world ([@B27]). Consecutively, several reports suggested transmission between pigs and humans causing livestock-associated *S. aureus* (LA-SA) colonization in 23--45% of pig-farmers ([@B44]; [@B22]; [@B37]) and 4.6% of pig-care veterinarians ([@B46]). The "One Health" concept recognizes that human health or livestock or wildlife health are interconnected and bound to the animal-human-ecosystems in which they (co)exist. Occupational exposure to swine has been associated with increased *Staphylococcus aureus* carriage, and increased risk of colonization and infections of different hosts ([@B45]; [@B20]; [@B35]; [@B25]; [@B18]; [@B13]). The risk of zoonotic transmission to humans demands our deep understanding of *S. aureus* contamination and ecology in the swine production.

The rapid development of resistance to multiple antimicrobial agents increases the difficulty treating *S. aureus* infections and biofilm production facilitate this organism to survive in the presence of antibiotics ([@B14]; [@B5]). Several studies have demonstrated that low doses of certain antibiotics could induce biofilm formation, indicating that biofilm regulation might be involved in the global response to external stresses, including antibiotics ([@B21]; [@B23]). Previous studies regarding quantitative correlation between biofilm formation and antibiotics resistance have yielded different results. For example, [@B31] concluded that the biofilm-positive strains have a higher tendency to exhibit multidrug resistance and methicillin resistance compared to biofilm-negative strains, while [@B16] indicated that there was no significant difference in the percentage of multi-drug-resistance (MDR) among biofilm producers and non-biofilm formers for both medical and non-medical personnel.

*Staphylococcus aureus* produces a wide variety of protein toxins, such as exfoliative toxins, Panton-Valentine leukocidin, hemolysins, enterotoxins, and toxic shock syndrome toxin. Among the large array of *S. aureus* virulence factors the MSCRAMMs (microbial surface component recognizing adhesive matrix molecules) includes different adhesins, which are essential for initial stages of infection ([@B28]). MSCRAMMs, which includes fibronectin binding proteins (FnbA and FnbB), fibrinogen binding proteins (ClfA, ClfB and Efb), capsule proteins (Capsule type 5 and 8) and collagen binding proteins (Cna), can bind to a variety of mammalian extracellular proteins and abiotic surfaces ([@B15]). Furthermore, the formation of a highly organized multicellular biofilm is related to the polysaccharide intercellular adhesin (PIA) production, which is controlled by the *ica* operon ([@B11]). Therefore, the numbers and combinations of toxin genes may contribute to the pathogenicity of *S. aureus*.

While previous studies have documented the prevalence of *S. aureus* isolates in bovine mastitis ([@B17]; [@B38]; [@B2]; [@B26]; [@B28]), there is a lack of data regarding the prevalence and characterization of *S. aureus* in pork production. A thorough understanding of the correlation between the observed polymorphism in genotype and virulence, and the diversity in production practices is important for targeted mitigation. In this study, an extensive study was conducted involving systematic sampling of three commercial swine farms, a contracted slaughterhouse for the designated farms, and a retail market in Xiamen, China to profile *S. aureus* isolates along the production, processing and retail chain. The data enabled tracking of the spread of *S. aureus* from pork production and a better understanding of the evolution of *S. aureus*.

Materials and Methods {#s1}
=====================

Bacterial Strains and Antibiotic Susceptibility
-----------------------------------------------

From September -- December 2014, three commercial swine farms with \> 5000 pigs, one large slaughterhouse and several terminal markets were selected from Xiamen City, People's Republic of China, and 501 samples were collected from these places for *S. aureus* isolation. Pigs were born and raised in these three commercial swine farms with distance for more than 25 km from each other and then were sent to the slaughterhouse. These three swine farms and the slaughterhouse were vertically integrated pork processing plant, meaning pigs originated from these three swine farms contracted to sell hogs exclusively to the slaughterhouse. However, terminal samples from the markets did not totally originate from the slaughterhouse tested in the present study.

Briefly, a total of 501 non-duplicate samples were collected from the pork industry, including three commercial swine farms (sty door and soil, *n* = 71; nasal swabs, *n* = 97), one slaughterhouse (pork, *n* = 173), and terminal markets (pork, *n* = 160). Isolation and identification of *S. aureus* were performed according to China's National Technical Standard GB4789.10-2010 and the special gene *nuc* was targeted by PCR for identifying *S. aureus* ([@B7]). Contamination with *S. aureus* was detected in 26.0% (130/501) of the total samples, and the prevalence of *S. aureus* was highest in the slaughterhouse (35.8%, 62/173) followed by the market (24.4%, 39/160) and the farm (17.3%, 29/168).

These isolates were assessed for antimicrobial susceptibility by the Kirby-Bauer disk diffusion method described by the Clinical and Laboratory Standards Institute ([@B9]). The antibiotic disks used (Hangzhou Microbial Reagent Co., Ltd., Hangzhou) included ciprofloxacin (5 μg), penicillin (10 μg), gentamicin (10 μg), tetracycline (30 μg), clarithromycin (15 μg), clindamycin (2 μg), chloramphenicol (30 μg), sulfamethoxazole-trimethoprim (25 μg), nitrofurantoin (30 μg), rifampin (5 μg), cephalothin (30 μg), minocycline (30 μg), cefoxitin (30 μg) and oxacillin (1 μg).

*agr* Genotyping
----------------

Bacterial genomic DNA template was extracted from the isolates by a commercial DNA extraction kit (Biomed, Beijing, China). The *agr* types (I--IV) were determined by a multiplex PCR assay as described by [@B19]. In brief, multiplex PCR was performed with the following primers: Pan (5′-ATG CAC ATG GTG CAC ATG C-3′), agr1 (5′-GTC ACA AGT ACT ATA AGC TGC GAT-3′), agr2 (5′-TAT TAC TAA TTG AAA AGT GGC CAT AGC-3′), agr3 (5′-GTA ATG TAA TAG CTT GTA TAA TAA TAC CCA G-3′) and agr4 (5′-CGA TAA TGC CGT AAT ACC CG-3′). These primers yield a PCR product of 441, 575, 323, or 659 bp corresponding to *agr* group I, II, III, and IV, respectively. Each assay contained 2 μL of prepared DNA template, 2.5 μL of 10× Easy Taq Buffer \[Takara Biomedical Technology (Beijing) Co., Ltd, China\], 1 μL of 10 mM deoxynucleotide triphosphate \[Takara Biomedical Technology (Beijing) Co., Ltd, China\], 1 μL of upstream and downstream primers (10 μM), and 0.125 μL of DNA polymerase (5 U/μL) \[Takara Biomedical Technology (Beijing) Co., Ltd, China\], and the final system volume was adjusted to 25 μL with sterile ultrapure water. The PCR conditions were as follows: 1 cycle at 94°C for 5 min; 26 cycles at 94°C for 30 s, 55°C for 30 s, and 72°C for 1 min; and finally 1 cycle at 72°C for 10 min. All PCR products were analyzed by electrophoresis on a 1.5% (w/v) agarose gel.

Identification of Virulence Determinants
----------------------------------------

The nucleotide sequences of all PCR primers used in this study and their respective amplified products and specific Tm (°C) are listed in **Table [1](#T1){ref-type="table"}**. All the oligonucleotide primers were synthesized by Sangon Biotech (Shanghai, China). Each assay contained 1 μL of prepared DNA template, 2.5 μL of 10× Easy Taq Buffer \[Takara Biomedical Technology (Beijing) Co., Ltd, China\], 1 μL of 10 mM deoxynucleotide triphosphate \[Takara Biomedical Technology (Beijing) Co., Ltd, China\], 1 μL of upstream and downstream primers (10 μM), and 0.125 μL of DNA polymerase (5 U/μL) \[Takara Biomedical Technology (Beijing) Co., Ltd, China\], and the final system volume was adjusted to 25 μL with sterile ultrapure water. The PCR conditions were as follows: an initial denaturation at 95°C for 5 min; 30 cycles of 95°C for 30 s, specific Tm for 30 s, and 72°C for 40--90 s depending on the PCR product length; and a final extension at 72°C for 10 min. Sequencing of the extracted PCR product was performed by Beijing Genomics Institute (Shenzhen, China) and the data were analyzed with the GenBank database using the BLAST algorithm at the National Center for Biotechnology Information web site^[1](#fn01){ref-type="fn"}^.

###### 

Target genes, putative function of encoded protein, primer sequence, and PCR conditions.

  Target gene   Primer name   Putative function of encoded protein              Primer sequence (5′---3′)         Product size (bp)   Tm (°C)   Reference
  ------------- ------------- ------------------------------------------------- --------------------------------- ------------------- --------- -----------
  *clfA*        clfA-F        Encoding Clumping factor, ClfA                    AAAACACGCAATTCGGAAAA              855                 53        [@B32]
                clfA-R                                                          GCAGTTGAAGTTACACCATTTAAGT                                       
  *clfB*        clfB-F        Encoding Clumping factor, ClfB                    TGTCGAATAAGCAGAATAAG              505                 49        [@B32]
                clfB-R                                                          GGTGATGATTGTGGTAAATC                                            
  *bbp*         bbp-F         Encoding bone sialoprotein-binding protein, Bbp   AACTACATCTAGTACTCAACAACAG         575                 55        [@B42]
                bbp-R                                                           ATGTGCTTGAATAACACCATCATCT                                       
  *ebpS*        ebpS-F        Encoding cell surface elastin-binding protein     CATCCAGAACCAATCGAAGAC             186                 55        [@B42]
                ebpS-R                                                          CTTAACAGTTACATCATCATGTTTATCTTTG                                 
  *cna*         cna-F         Encoding collagen-binding protein                 GTCAAGCAGTTATTAACACCAGAC          423                 55        [@B42]
                cna-R                                                           AATCAGTAATTGCACTTTGTCCACTG                                      
  *eno*         eno-F         Encoding laminin binding protein                  ACGTGCAGCAGCTGACT                 302                 55        [@B42]
                eno-R                                                           CAACAGCATYCTTCAGTACCTTC                                         
  *fib*         fib-F         Encoding fibrinogen binding protein, Fib          CTACAACTACAATTGCCGTCAACAG         404                 55        [@B42]
                fib-R                                                           GCTCTTGTAAGACCATTTTCTTCAC                                       
  *fnbA*        fnbA-F        Encoding fibronectin-binding protein A            GTGAAGTTTTAGAAGGTGGAAAGATTAG      643                 55        [@B42]
                fnbA-R                                                          GCTCTTGTAAGACCATTTTTCTTCAC                                      
  *fnbB*        fnbB-F        Encoding fibronectin-binding protein B            GTAACAGCTAATGGTCGAATTGATACT       524                 55        [@B42]
                fnbB-R                                                          CAAGTTCGATAGGAGTACTATGTTC                                       
  *cap5*        cap5-F        Encoding CP5 synthesis enzyme                     ATGAGGATAGCGATTGAAAA              518                 49        [@B32]
                cap5-R                                                          CGCTTCTTAATCACTTTTGC                                            
  *cap8*        cap8-F        Encoding CP8 synthesis enzyme                     ATCGAAGAACATATCCAAGG              834                 46        [@B32]
                cap8-R                                                          TTCATCACCAATACCTTTTA                                            
  *icaA*        icaA-F        Encoding intercellular adhesion protein A         CTTGCTGGCGCAGTCAATAC              178                 55        [@B34]
                icaA-R                                                          CCAACATCCAACACATGGCA                                            
  *icaC*        icaC-F        Encoding intercellular adhesion protein C         CTTGGGTATTTGCACGCATT              209                 55        [@B34]
                icaC-R                                                          GCAATATCATGCCGACACCT                                            
  *icaD*        icaD-F        Encoding intercellular adhesion protein D         CGCTATATCGTGTGTCTTTTGGA           164                 55        [@B34]
                icaD-R                                                          TCGCGAAAATGCCCATAGTT                                            
  *bap*         bap-F         Encoding biofilm-associated protein, Bap          CCCTATATCGAAGGTGTAGAATTGCAC       971                 60        [@B34]
                bap-R                                                           GCTGTTGAAGTTAATACTGTACCTGC                                      
  *pvl*         pvl-F         Encoding Panton-Valentine leukocidin              GTCGTTAGGAATAATCACTCC             423                 48        [@B32]
                pvl-R                                                           CCTGTTGATGGACCACTATTAA                                          
  *tst*         tsst-F        Encoding toxic shock syndrome toxin-1             TTTTTTATCGTAAGCCCTTTGTTGC         550                 51        [@B32]
                tsst-R                                                          CACCCGTTTTATCGCTTGAA                                            
  *hla*         hla-F         Encoding alpha-haemolysin precursor               TGCCGCAGATTCTGATATTAA             845                 51        [@B32]
                hla-R                                                           TTTCTGAAGAACGATCTGTCCA                                          
  *hlb*         hlb-F         Encoding beta-haemolysin precursor                GCGGTTGTGGATTCGATAAT              524                 50        [@B32]
                hlb-R                                                           GGCTTTGATTGGGTAATGATC                                           
  *hld*         hld-F         Encoding delta-haemolysin precursor               GGGATGGCTTAATAACTCATACTT          236                 48        [@B32]
                hld-R                                                           CAGAGATGTGATGGAAAATAGTTGA                                       
  *eta*         eta-F         Encoding exfoliative toxin A                      TTGTAAAAGGACAAACAAGTGC            544                 49.4      [@B32]
                eta-R                                                           TTCCCAATACCAACACCA                                              
  *etb*         etb-F         Encoding exfoliative toxin B                      TTACAAGCAAAAGAATACAGCG            641                 50        [@B32]
                etb-R                                                           GGAAGATTATGTTGTCCGCC                                            

Biofilm Formation
-----------------

Quantification of biofilm formation was performed by spectrophotometry in microplates (Nest Biotechnology Co., Ltd. Wuxi, China) using crystal violet staining as previously described ([@B34]). Briefly, 20 μL of bacterial log phase culture was added to 200 μL of fresh 1% glucose BHI in 96-well flat-bottom microtiter plates. *S. aureus* ATCC25923 (biofilm-forming) and *S. epidermidis* ATCC12228 (not biofilm-forming) were used as positive and negative controls, respectively. BHI without bacteria served as the blank. The plates were incubated at 37°C for 24, 48, and 72 h under aerobic conditions. After each sampling time, wells were washed three times with 300 μL of sterile phosphate-buffered saline (PBS; pH 7.2) and drained by inversion. Subsequently, 200 μL of methanol was added to each well and the plates were dried for 15 min. The adherent cells were stained with 150 μL of 0.1% crystal violet solution for 15 min and then washed twice with sterile water. Bound crystal violet was dissolved by treatment with 150 μL of 95% ethanol for 10 min, and OD~570~ was measured for the stained bacteria and control wells. The experiment was performed in triplicate. An OD~570~ value of 0.3 was taken as the cutoff point to differentiate between biofilm producers and non-biofilm-producer strains \[cut-off value (ODc) = average OD of negative control + 3× standard deviation (SD) of negative control\] ([@B34]). The quantitative classification of biofilm production based on ODc and average OD values was carried out, resulting in four categories of strains: strong biofilm producers (OD \> 4 × ODc), moderate biofilm producers (4 × ODc \> OD \> 2 × ODc), weak biofilm producers (2 × ODc \> OD \> ODc), and no biofilm producers (OD \< ODc) ([@B34]).

Growth Rate Analysis
--------------------

The growth of 12 strong, 12 moderate and 12 weak biofilm formers were measured according to [@B36]. Briefly, isolates were cultured in BHI agar for 18--24 h and adjusted to 0.5 McFarland units with 0.85% NaCl medium, and diluted 1: 20 in BHI medium. The cultures were incubated for 24 h at 37°C with shaking at 200 rpm and the bacterial growth was monitored by measuring the OD~600~ values of the culture. All experiments include three independent replicates.

Statistical Analysis
--------------------

Statistical analysis was performed with SPSS v.22.0 (SPSS Inc., Chicago, IL, United States). Differences groups were compared using the chi-squared test and a *p*-value of \<0.05 was deemed to be significant. Spearman's rank correlation test was used for comparison of biofilm formation ability and multi-drug-resistance (MDR).

Results
=======

*agr* Genotyping
----------------

By multiplex PCR, the *agr* types were successfully identified in 109 isolates, and 21 isolates were non-typeable for *agr* locus. As shown in **Table [2](#T2){ref-type="table"}**, the *agr* I was most prevalent (39.2%; 51/130), followed by *agr* IV (32.3%; 42/130), *agr* II (9.2%; 12/130) and *agr* III (3.1%; 4/130). All swine farms isolates belonged to *agr* IV, whereas *S. aureus* isolated from slaughterhouse and retail indicated diverse *agr* types.

###### 

The *agr* types of 130 *S. aureus* isolates from different stages of pork production.

  *agr* group        Number of *S. aureus* isolates from various samples^a^   Total                     
  ------------------ -------------------------------------------------------- ------------ ------------ ------------
  I                  0 (0)                                                    15 (24.2%)   36 (92.3%)   51 (39.2%)
  II                 0 (0)                                                    12 (19.4%)   0 (0)        12 (9.2%)
  III                0 (0)                                                    4 (6.5%)     0 (0)        4 (3.1%)
  IV                 29 (100%)                                                11 (17.7%)   2 (5.1%)     42 (32.3%)
  *agr* (negative)   0 (0)                                                    20 (32.3)    1 (2.6%)     21 (16.2%)
  Total              29                                                       62           39           130

a

The number in parentheses represents the percentage of isolates in the corresponding genotype

.

Prevalence and Distribution of Virulence Genes
----------------------------------------------

As illustrated in **Figure [1](#F1){ref-type="fig"}**, nearly all isolates harbored the *hla* (95.4%), *hlb* (100%) and *hld* (98.5%) genes, encoding alpha-, beta-, and delta-hemolysins respectively. No isolate harbored *bap*, *pvl*, or *tsst*. It was found that the *bbp*, *cna* and *cap8* genes were detected only in isolates obtained from slaughterhouse and terminal markets. As shown in **Table [3](#T3){ref-type="table"}**, the most frequent numbers of toxin genes per isolate were 11∼14 in all *S. aureus* isolates (**Table [3](#T3){ref-type="table"}**). Notably, one isolate harbored 16 toxin genes and 5 isolates harbored 15 toxin genes, which were obtained from slaughterhouse (**Table [3](#T3){ref-type="table"}**).

![The distribution of 22 toxin genes in *S. aureus* isolates from different stages of pork production. The percentage of strains that were positive for each toxin gene was calculated based on the origin of each sample isolate. Pearson's chi-square test (two-tailed) was used to test the difference in the virulence determinants distribution among isolates from different sources and run based on multiple group comparison of different sources. ^∗^Demonstrates that the distribution of toxin genes was statistically significantly different in isolates from different sources (*p* \< 0.05); ^∗∗^demonstrates that the distribution of toxin genes was more significantly different in isolates from different food sources (*p* \< 0.01).](fmicb-09-01876-g001){#F1}

###### 

The toxin genes number of *S. aureus* isolates from different stages of pork production.

  Number of the toxin gene per isolate (*n*)   Number of *S. aureus* isolates^a^   Total number of isolates (130)^b^                
  -------------------------------------------- ----------------------------------- ----------------------------------- ------------ ------------
  16                                           0 (0)                               1 (1.6%)                            0 (0)        1 (0.8%)
  15                                           0 (0)                               5 (8.1%)                            0 (0)        5 (3.8%)
  14                                           1 (3.4%)                            13 (21.0%)                          5 (12.8%)    19 (14.6%)
  13                                           14 (48.3%)                          9 (14.5%)                           10 (25.6%)   33 (25.4%)
  12                                           13 (44.8%)                          18 (29.0%)                          14 (35.9%)   45 (34.6%)
  11                                           1 (3.4%)                            5 (8.1%)                            6 (15.4%)    12 (9.2%)
  10                                           0 (0)                               3 (4.8%)                            3 (7.7%)     6 (4.6%)
  9                                            0 (0)                               2 (3.2%)                            0 (0)        2 (1.5%)
  8                                            0 (0)                               2 (3.2%)                            0 (0)        2 (1.5%)
  7                                            0 (0)                               2 (3.2%)                            0 (0)        2 (1.5%)
  6                                            0 (0)                               2 (3.2%)                            1 (2.6%)     3 (2.3%)

a

The number in parentheses represents the percentage of isolates with the corresponding number of toxin genes for all

S. aureus

isolates of the same part in pork production.

b

The number in parentheses represents the percentage of isolates with the corresponding number of toxin genes for all

S. aureus

isolates

.

The average toxin gene number was also examined based on *agr* genotyping, and a higher average number of toxin genes was found in the *agr*-positive isolates compared to *agr*-negative isolates. The *agr*-positive isolates were associated with a high average number of toxin genes (averaging 13.2 for *agr* II, 12.6 for *agr* I, 12.6 for *agr* IV and 12.0 for *agr* III), whereas the *agr*-negative isolates were associated with a lower average number of toxin genes (averaging 9.9) (**Figure [2](#F2){ref-type="fig"}**). The distribution of virulence genes differed among the isolates according to the *agr* genotyping. Among the MSCRAMMs genes, the prevalence of 3 genes was significantly different between the *agr*-positive and *agr*-negative isolates: *clfA* (*p* \< 0.01), *clfB* (*p* \< 0.01) and *fnbA* (*p* \< 0.05). The capsule multiple type (carriage of both capsule type 5 and 8) (*p* \< 0.01) and *icaC* gene (*p* \< 0.01) were positively associated with *agr*-positive isolates (**Figure [3](#F3){ref-type="fig"}**).

![The toxin gene content of *S. aureus* isolates based on *agr* genotyping. The average number of toxin genes was calculated based on the total number of toxin genes detected in each *agr* group divided by the total number of isolates in each *agr* group. The number in parentheses on the *Y*-axis represents the total number of isolates in the corresponding *agr* group.](fmicb-09-01876-g002){#F2}

![Distribution of staphylococcal virulence associated genes between *agr*-positive and *agr*-negative *S. aureus*. Pearson's chi-square test (two-tailed) was used to test the difference in the virulence determinants distribution between *agr*-positive isolates and *agr*-negative isolates. ^∗^Demonstrates that the distribution of toxin genes was statistically significantly different in isolates from different *agr* types (*p* \< 0.05); ^∗∗^Demonstrates that the distribution of toxin genes was more significantly different in isolates from different *agr* types (*p* \< 0.01).](fmicb-09-01876-g003){#F3}

Quantification of Biofilm Biomass and Growth Rate Analysis
----------------------------------------------------------

Biofilm formation was analyzed, and all the isolates were able to form biofilm. The biomass of biofilms formed by most isolates increased continuously during incubation for 72 h at 37°C (**Table [4](#T4){ref-type="table"}**). Biofilm strong producers are mainly in slaughterhouse and biofilm biomass increase with time. No significant difference in the growth rates of the strong, moderate and weak biofilm formers was observed, indicating that the difference in biofilm formation was not due to the growth rate.

###### 

Biofilm phenotype of 130 *S. aureus* isolates at different time points.

                           Number of *S. aureus* biofilm phenotype^a,b^                                                                  
  ------------------ ----- ---------------------------------------------- --------- --------- -------- --------- --------- -- ---------- ---------
  Swine farms        29    6                                              21        2                  13        16           2          27
                           (20.7%)                                        (72.4%)   (6.9%)             (44.8%)   (55.2%)      (6.9%)     (93.1%)
  Slaughterhouse     62    5                                              27        30        1        13        48           2          60
                           (8.1%)                                         (43.6%)   (48.4%)   (1.6%)   (21.0%)   (77.4%)      (3.2%)     (96.8%)
  Terminal markets   39    7                                              8         24        1        4         34           4          35
                           (18.0%)                                        (20.5%)   (61.5%)   (2.6%)   (10.3%)   (87.2%)      (10.26%)   (89.7%)
  Total              130   18                                             56        56        2        30        98           8          122
  (%)                      (13.8%)                                        (43.1%)   (43.1%)   (1.5%)   (23.1%)   (75.4%)      (6.2%)     (93.8%)

a

The number in parentheses represents the percentage of isolates with the corresponding number of biofilm phenotype for all

S. aureus

isolates of the same part in pork production.

b

Biofilm-forming ability was measured after 24, 48, and 72 h at 37°C in terms of biofilm biomass by crystal violet staining. The results are presented by optical density (OD) determination of three independent repeats and compared to ATCC 25923 (biofilm-positive) and ATCC12228 (biofilm-negative)

.

Correlation Between Virulence Genes and Antibiotic Resistance in Biofilm Producing *S. aureus*
----------------------------------------------------------------------------------------------

The relationship between prevalence of biofilm-associated genes and biofilm formation ability (incubation for 24 h at 37°C) of *S. aureus* isolates was further analyzed (**Figures [4](#F4){ref-type="fig"}**, **[5](#F5){ref-type="fig"}**). Considering the studied gene status, 19 different gene patterns were observed (**Table [5](#T5){ref-type="table"}**). The most prevalent gene pattern was *clfA*-*clfB*-*ebpS*-*eno*-*fib*-*cap5*-*icaA*-*icaC*-*icaD* which was identified in 13 (10.0%) of 130 isolates. However, there was only one strong biofilm producer, nine moderate biofilm producers and three weak biofilm producers in this genes pattern. Conversely, among the genes patterns of *clfA*-*clfB*-*ebpS*-*eno*-*fib*-*fnbB*-*cap5*-*cap8*-*icaA*-*icaC*-*icaD* (3.8%,5/130), *clfB*-*eno*-*fib*-*fnbB*-*cap5*-*cap8*-*icaA*-*icaD* (1.5%, 2/130), *clfB*-*bbp*-*eno*-*fib*-*cap5*-*cap8*-*icaA*-*ic*aC-*icaD* (1.5%, 2/130), *clfA*-*clfB*-*eno*-*fib*-*fnbB*-*cap5*-*cap8*-*icaA*-*icaD* (1.5%, 2/130), and *clfB*-*eno*-*fib*-*cap5*-*cap8*-*icaA*-*icaC*-*icaD* (1.5%, 2/130), all isolates showed strong biofilm formation ability (**Table [5](#T5){ref-type="table"}**). A comparison between the strong, moderate, and weak biofilm producers in the isolates showed a significant difference in the prevalence of virulence genes among these isolates.

![Distribution of biofilm-associated genes of *S. aureus* isolates based on biofilm formation ability. Pearson's chi-square test (two-tailed) was used to test the difference in the virulence determinants distribution among different ability of biofilm ability. ^∗^Demonstrates that the distribution of toxin genes was statistically significantly different (*p* \< 0.05); ^∗∗^demonstrates that the distribution of toxin genes was more significantly different (*p* \< 0.01).](fmicb-09-01876-g004){#F4}

![Diagram showing the antibiotic resistance pheno- and *agr* types, virulence genes profiles and biofilm phenotype of *S. aureus* isolated from different stages of pork production. The diagram was established on the basis of the presence and absence of selected determinants. For antibiotic resistance phenotype, black indicates resistance, gray indicates intermediate, and white indicates susceptible. CIP, ciprofloxacin; PEN, Penicillin; GEM, gentamicin; TET, tetracycline; CLR, clarithromycin; CHL, chloramphenicol; SXT, trimethoprim-sulfamethoxazole; NIT, nitrofurantoin; RIF, rifampicin; CLI, clindamycin; CEF, cephalothin; MIN, minocycline; OXA, oxacillin; FOX, cefoxitin; For virulence genes profiles, black indicates presence and white indicates absence. For biofilm phenotype, black indicates strong, gray indicates moderate, and white indicates weak.](fmicb-09-01876-g005){#F5}

###### 

The prevalence of biofilm related genes pattern and their associations with biofilm production in 130 *S. aureus* from different stages of pork production.

  Biofilm related genes patterns                               Number of *S. aureus* biofilm phenotype^a^   Total       
  ------------------------------------------------------------ -------------------------------------------- ------- --- ----
  *clfA*-*clfB-ebpS-eno-fib-cap5-icaA-icaC-icaD*               1                                            9       3   13
  *clfA-clfB-ebpS-eno-fib-fnbA-cap5-icaA-icaC-icaD*            1                                            5       3   9
  *clfA-clfB-ebpS-eno-fib-fnbB-cap5-icaA-icaC-icaD*            2                                            5       0   7
  *clfA-clfB-ebpS-eno-fib-fnbB-cap5-cap8-icaA-icaC-icaD*       5                                            0       0   5
  *clfA-clfB-eno-fib-fnbB-cap5-cap8-icaA-icaC-icaD*            1                                            3       1   5
  *clfA-clfB-ebpS-cna-eno-fib-cap5-cap8-icaA-icaC-icaD*        2                                            2       0   4
  *clfB-bbp-eno-fib-fnbB-cap8-icaA-icaC-icaD*                  2                                            0       1   3
  *clfB-eno-fib-fnbB-cap5-cap8-icaA-icaD*                      2                                            0       0   2
  *clfB-bbp-eno-fib-cap5-cap8-icaA-icaC-icaD*                  2                                            0       0   2
  *clfA-clfB-eno-fib-fnbB-cap5-cap8-icaA-icaD*                 2                                            0       0   2
  *clfB-eno-fib-cap5-cap8-icaA-icaC-icaD*                      2                                            0       0   2
  *clfA-clfB-ebpS-eno-fib-cap5-cap8-icaA-icaC-icaD*            1                                            1       0   2
  *clfA-clfB-ebpS-fnbB-cap5-cap8-icaA-icaC-icaD*               1                                            0       1   2
  *clfA-clfB-ebpS-cna-eno-fib-fnbB-cap5-cap8-icaA-icaC-icaD*   0                                            2       0   2
  *clfA-clfB-ebpS-eno-fib-fnbA-cap5-icaC-icaD*                 0                                            2       0   2
  *clfA-clfB-ebpS-fib-fnbB-cap5-cap8-icaA-icaC-icaD*           0                                            2       0   2
  *clfA-clfB-ebpS-eno-fib-cap8-icaA-icaC-icaD*                 0                                            2       0   2
  *clfB-eno-fib-fnbB-cap5-cap8-icaA-icaC-icaD*                 0                                            1       1   2
  *clfA-clfB-ebpS-fib-cap8-icaA-icaC-icaD*                     0                                            1       1   2

a

Biofilm phenotype was measured after 24 h at 37°C

.

To determine whether biofilm formation was correlated with resistance to any particular antibiotic(s), we compared the biofilm forming capacities (incubation for 24 h at 37°C) among isolates with different resistance profiles for the 14 antibiotics (**Table [6](#T6){ref-type="table"}**). Resistance to ciprofloxacin, gentamicin, tetracycline, clarithromycin, clindamycin and trimethoprim-sulfamethoxazole were significantly higher in moderate biofilm producers and weak biofilm producers than in strong biofilm producers (**Table [6](#T6){ref-type="table"}**). Notably, resistance to nitrofurantoin was only found in strong biofilm producers (7.1%, 4/56) and moderate biofilm producers (1.8%, 1/56) (**Table [6](#T6){ref-type="table"}**). Resistance to penicillin, cefoxitin and chloramphenicol showed no significant difference among strong biofilm producers, moderate biofilm producers and weak biofilm producers (**Table [6](#T6){ref-type="table"}**). Regarding multidrug resistance, no significant association to strong, moderate or weak biofilm producers was observed (**Table [7](#T7){ref-type="table"}**).

###### 

Biofilm formation and antibiotic resistance pattern of 130 *S. aureus* isolates from different stages of pork production.

  Antibiotic category   Antibiotic agent                Percentage of antibiotic-resistant strains in different biofilm phenotype                   
  --------------------- ------------------------------- --------------------------------------------------------------------------- --------------- ---------------
  β-lactamase           Penicillin                      85.7% (48/56)                                                               98.2% (55/56)   94.4% (17/18)
                        Oxacillin                       17.9% (10/56)                                                               1.8% (1/56)     11.1% (2/18)
                        Cefoxitin                       19.6% (11/56)                                                               10.7% (6/56)    27.8% (5/18)
                        Cephalothin                     8.9% (5/56)                                                                 1.8% (1/56)     11.1% (2/18)
  Fluoroquinolones      Ciprofloxacin                   17.9% (10/56)                                                               53.6% (30/56)   66.7% (12/18)
  Aminoglycosides       Gentamicin                      14.3% (8/56)                                                                35.7% (20/56)   55.6% (10/18)
  Tetracyclines         Tetracycline                    46.4% (26/56)                                                               58.9% (33/56)   83.3% (15/18)
                        Minocycline                     14.3% (8/56)                                                                0               16.7% (3/18)
  Macrolides            Clarithromycin                  32.1% (18/56)                                                               60.7% (34/56)   72.2% (13/18)
  Lincomycins           Clindamycin                     30.4% (17/56)                                                               60.7% (34/56)   83.3% (15/18)
  Chloramphenicols      Chloramphenicol                 28.6% (16/56)                                                               14.3% (8/56)    38.9% (7/18)
  Sulfonamides          Trimethoprim-sulfamethoxazole   21.4% (12/56)                                                               53.6% (30/56)   66.7% (12/18)
  Nitrofurans           Nitrofurantoin                  7.1% (4/56)                                                                 1.8% (1/56)     0
  Rifamycins            Rifampicin                      17.9% (10/56)                                                               1.8 % (1/56)    27.8% (5/18)

a

The number in parentheses represents the corresponding number of biofilm phenotype for

S. aureus

isolates of antibiotic resistance. Biofilm phenotype was measured after 24 h at 37°C, and the number of strong biofilm producers, moderate biofilm producers and weak biofilm producers were 56, 56 and 18, respectively

.

###### 

Occurrence of multidrug resistant pattern and their associations with biofilm phenotype in 130 *S. aureus* from different stages of pork production.

  Number of antibiotic category   Number of *S. aureus* biofilm phenotype^a^   Total number of isolates                
  ------------------------------- -------------------------------------------- -------------------------- ------------ ------------
  9                                                                                                       1 (5.6%)     1 (0.8%)
  8                               6 (10.7%)                                    4 (7.1%)                   2 (11.1%)    12 (9.2%)
  7                               6 (10.7%)                                    16 (28.6%)                 6 (33.3%)    28 (21.5%)
  6                               3 (5.4%)                                     9 (16.1%)                  4 (22.2%)    16 (12.3%)
  5                               1 (1.8%)                                     1 (1.8%)                   2 (11.1%)    4 (3.1%)
  4                               1 (1.8%)                                     3 (5.4%)                   1 (5.6%)     5 (3.8%)
  3                               3 (5.4%)                                     1 (1.8%)                                4 (3.1%)
  2                               15 (26.8%)                                   7 (12.5%)                  0            22 (16.9%)
  1                               13 (23.2%)                                   14 (25.0%)                 1 (5.6%)     28 (21.5%)
  0                               8 (14.3%)                                    1 (1.8%)                   1 (5.6%)     10 (7.7%)
  Total                           56 (43.1%)                                   56 (43.1%)                 18 (13.8%)   130 (100%)

a

Biofilm phenotype was measured after 24 h at 37°C

.

Discussion
==========

The *agr* (accessory gene regulator) system is a peptide quorum-sensing system present in all the Staphylococci and a dominant regulator of pathogenesis and biofilm development in *S. aureus* ([@B6]; [@B33]). All the swine farms isolates were *agr* type IV, whereas the slaughterhouse and terminal markets isolates indicated diverse *agr* types. In addition, isolates belonging to *agr*-positive group had a higher number of toxin genes than those belonging to *agr*-negative group (*p* \< 0.05), suggesting that *agr* profiles may be associated with the virulence potential of *S. aureus*, which is consistent with a previous finding ([@B8]). Raw meat isolates (belonging to *agr* I) exhibited a great ability to form strong biofilms than swine farms isolates (belonging to *agr* IV). Previous studies have shown that biofilm formation in *S. aureus* isolated from bovine mastitis with *agr* I is higher than those with other *agr* types ([@B4]; [@B3]; [@B24]).

The prevalence of virulence genes involved in biofilm formation and staphylococcal toxin genes were investigated. Most biofilm-producing isolates were positive for MSCRAMM, capsule type and *ica* group genes. The data show a significant association between the prevalence rate of MSCRAMM, capsule type and *ica* group genes among isolates producing weak, moderate and strong biofilms. Approximately 92.3% (120/130) of all isolates harbored *icaA* and *icaD* genes simultaneously, which were similar to those from previous studies ([@B41]; [@B34]). Moreover, although both *pvl* and *tst* genes were not detected in the tested isolates, hemolysins and enterotoxin-producing genes (data not shown) were found. This suggests that these isolates exhibit pathogenic potential.

In the present study, all *S. aureus* isolates were biofilm producers. Biofilm formation is influenced by numerous factors, such as sugar content and concentration (glucose versus lactose), proteolytic enzymes and biofilm-associated genes, etc. ([@B10]). In this study, biofilm production was higher for raw meat isolates compared to swine farms isolates. There was a difference in the prevalence of several genes involved in adhesion and biofilm production between raw meat and swine farms isolates. However, further studies are required to quantify the expression of relevant genes. Moreover, biofilm biomass increased proportionally as biofilms aged, which is accordance with previous findings ([@B1]). High variability in biofilm biomass was found among isolates throughout the time course of biofilm formation (24 -- 72 h), which is in accordance with previous findings ([@B30]; [@B43]). Moreover, our study demonstrated the potential association between antibiotic resistance and biofilm-forming ability of *S. aureus*. Apart from resistance to penicillin, the high prevalence of resistance to ciprofloxacin, gentamicin, tetracycline, clarithromycin, clindamycin and trimethoprim-sulfamethoxazole were mainly observed in moderate and weak biofilm producers. Together, [@B36] reported that for *Acinetobacter baumannii*, there was a statistically negative correlation between antibiotic resistance and biofilm forming capacity, suggesting that biofilm-forming strains are less dependent on antibiotic resistance than no biofilm-forming strains for survival. Previous studies have demonstrated that biofilm resistance to antimicrobials is multifaceted, including reduced penetration of the agent into biofilms due to the presence of extracellular matrix, biofilm heterogeneity and biofilm-specific phenotypes such as expression of efflux pump and persister cells ([@B40]; [@B1]). Moreover biofilm resistance is known to vary from one microorganism to another ([@B29]). Thus our further study will focus on the enhancement in resistance of our *Staphylococcus aureus* after biofilm formation.

In summary, our study revealed *agr* type diversity, virulence potential, antibiotic multiresistance and high biofilm formation ability of *S. aureus* isolated from pork production. All swine farms isolates belonged to *agr* IV, whereas *S. aureus* isolated from slaughterhouse and retail indicated diverse *agr* types. Raw meat isolates (belonging to *agr* I) exhibited a great ability to form strong biofilms than swine farms isolates (belonging to *agr* IV). Most biofilm-producing isolates were positive for MSCRAMM, capsule type and *ica* group genes. The results illustrate a significant association between the prevalence rate of MSCRAMM, capsule type and *ica* group genes among isolates producing weak, moderate and strong biofilms. Clarifying these mechanisms could provide novel insights that would prevention against *S. aureus* biofilm-related infections.

Author Contributions
====================

HY and LS participated in the design of this study. RC, DX, LS, and CL provided assistance for concepts, design, literature search, data acquisition, and manuscript preparation. YZ collected important background information, carried out the study, and performed the statistical analysis. HY and YZ drafted the manuscript. HY and DX performed the manuscript review. All the authors have read and approved the content of the manuscript.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

**Funding.** This work was supported by the National Key Basic Research Program (2016YFD0500606), the Science and Technology Planning Project of Guangdong Province, China (2014A020214001 and 2016A020219001), the Fundamental Research Funds for the Central Universities, SCUT (D2170320), and the Central Universities constructs the world first-class university (discipline) and Characteristic Development Guidance Special Fund (K5174960).

[www.ncbi.nlm.nih.gov](http://www.ncbi.nlm.nih.gov)

[^1]: Edited by: Learn-Han Lee, Monash University Malaysia, Malaysia

[^2]: Reviewed by: Maria José Saavedra, Universidade de Trás-os-Montes e Alto Douro, Portugal; Florence Dubois-Brissonnet, AgroParisTech-Institut des Sciences et Industries du Vivant et de l'Environnement, France

[^3]: ^†^These authors have contributed equally to this work

[^4]: This article was submitted to Food Microbiology, a section of the journal Frontiers in Microbiology
